Insights Into Ardelyx (ARDX) Q4: Wall Street Projections for Key Metrics

Core Insights - Ardelyx (ARDX) is expected to report quarterly earnings of $0.02 per share, unchanged from the same period last year, with revenues projected at $117.57 million, reflecting a year-over-year increase of 1.2% [1] - The consensus EPS estimate has been revised downward by 50% over the past 30 days, indicating a reassessment by analysts [1] Revenue Projections - Analysts predict 'Revenues- Product sales, net' to reach $114.14 million, representing a 2.8% increase from the prior-year quarter [4] - 'Product sales- IBSRELA' are expected to reach $85.75 million, indicating a significant increase of 59.3% from the prior-year quarter [4] - Conversely, 'Product sales- XPHOZAH' are projected to be $28.39 million, reflecting a decrease of 50.3% from the prior-year quarter [4] Stock Performance - Ardelyx shares have increased by 1.8% over the past month, contrasting with a decline of 1.4% in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [5]